mevalonic acid has been researched along with Epstein-Barr Virus Infections in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ersing, I; Gewurz, BE; Guo, R; Jiang, S; Nobre, L; Trudeau, S; Wang, LW; Wang, Z; Weekes, MP; Zhao, B | 1 |
1 other study(ies) available for mevalonic acid and Epstein-Barr Virus Infections
Article | Year |
---|---|
Epstein-Barr virus subverts mevalonate and fatty acid pathways to promote infected B-cell proliferation and survival.
Topics: Alkyl and Aryl Transferases; B-Lymphocytes; Cell Proliferation; Cell Survival; Cholesterol; Epstein-Barr Virus Infections; Epstein-Barr Virus Nuclear Antigens; Fatty Acids; Herpesvirus 4, Human; Host Microbial Interactions; Humans; Metabolic Networks and Pathways; Mevalonic Acid; Proto-Oncogene Proteins c-myc; rab GTP-Binding Proteins; Sterol Regulatory Element Binding Protein 2; Viral Proteins | 2019 |